Results 131 to 140 of about 51,976 (269)

Progressive Linear Bullous Eruption in a Young Athlete: A Diagnostic Challenge

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Chon‐Wai Jeremy Chan   +4 more
wiley   +1 more source

Detection of Diagnostic Antibodies in Immune‐Mediated Diseases: A Focus on Antigens and Technologies

open access: yesChemBioChem, Volume 27, Issue 9, 14 May 2026.
This review explores autoantibody detection in immune‐mediated diseases, highlighting autoantigens including post‐translational modifications. We compared enzyme‐linked immunosorbent assay and indirect immunofluorescence with automated chemiluminescence platforms.
Silvia Bracci   +5 more
wiley   +1 more source

Severe Occupational Hypersensitivity Pneumonitis: A Case Series of Four Patients Requiring Lung Transplantation

open access: yesAmerican Journal of Industrial Medicine, Volume 69, Issue 5, Page 323-334, May 2026.
ABSTRACT Hypersensitivity pneumonitis (HP) is an immune‐mediated interstitial lung disease triggered by repeated inhalation of organic or chemical antigens. Occupational exposures account for approximately 19% of all cases. Early diagnosis, identification of the responsible antigen(s), and immediate avoidance of exposure are crucial to prevent ...
Ludwig Frei‐Stuber   +6 more
wiley   +1 more source

Bullous allergic contact dermatitis to lidocaine [PDF]

open access: yes, 2009
Barkema, L.W.   +3 more
core   +4 more sources

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Comprehensive Review of Types, Pathophysiology, and Treatment Approaches

open access: yesBrain and Behavior, Volume 16, Issue 5, May 2026.
Chronic inflammatory demyelinating polyneuropathy is an autoimmune disorder causing demyelination, leading to distal weakness, sensory loss, and autonomic dysfunction. Immune activation triggers macrophage‐mediated myelin damage and conduction failure.
Ayesha Khan   +11 more
wiley   +1 more source

Bullous dermatoses secondary to anti-PD-L1 agents: a case report and review of the literature [PDF]

open access: yes, 2019
Immune checkpoint inhibitors are used to treat numerous malignancies but may be associated with severe adverse events. Bullous dermatoses, chiefly bullous pemphigoid (BP), are potentially progressive adverse events that cause blistering skin lesions and ...
Choi, Jennifer N   +3 more
core  

Scrotal Abscess Mimicking Fixed Drug Eruption Under Ibuprofen Therapy: A Diagnostic Pitfall

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Concurrent NSAID therapy can pharmacologically mask early scrotal abscess, generating a presentation that fulfills clinical and historical criteria for fixed drug eruption. Ibuprofen simultaneously acts as a recognized causative agent and suppresses infectious inflammatory signs.
Youssef Maachi   +6 more
wiley   +1 more source

Bullous retinoschisis

open access: yesIndian Journal of Ophthalmology, 2019
Sabia Handa   +3 more
openaire   +3 more sources

Combined Use of Botulinum Toxin A and Profhilo for Upper Face Rejuvenation: A Randomized Clinical Trial

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Hyaluronic acid (HA) and Botulinum toxin A (BTX‐A) treatments are highly regarded for their effectiveness in facial rejuvenation. Aim To investigate whether adding Profhilo enhances the effects of BTX‐A for frontal skin rejuvenation.
Zahra Saffarian   +9 more
wiley   +1 more source

Complicated Spastic Paraparesis: Study of a Patient With a De Novo Pathogenic Variant in ELOVL1

open access: yesInternational Journal of Developmental Neuroscience, Volume 86, Issue 3, May 2026.
A de novo ELOVL1 variant causes syndromic spastic paraparesis with congenital ichthyosis, cerebellar signs and white matter abnormalities. Long‐term clinical and MRI follow‐up showed mild motor and neuroradiological progression with preserved intelligence and subtle cognitive efficiency decline, supporting the hypothesis of a primary neuronal disease ...
Ylenia Vaia   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy